Galectin-3C

N/A

Report date: 2024/11/19 14:42:30
NME

Base Information

Drug NameGalectin-3C
Drug Alias NameGal-3C
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGalectin-3 inhibitors
TargetsGalectin-3
Therapy Area/IndicationsFibrosisBreast NeoplasmsMultiple Myeloma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMandalMed Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUc San FranciscoTexas Tech University Health Sciences CenterMandalMed Inc
Active IndicationsN/A
Inactive IndicationsFibrosisBreast NeoplasmsMultiple Myeloma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A